R Squared’s Clover Health Investments CLOV Stock Holding History

R Squared’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-37,442	Closed	-$65.9K	–	554
2026 Q1	$65.9K	Buy	+37,442	New	+$81.2K	0.04%	400

Other funds holding CLOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

R Squared's CLOV Position: Q2 2026 in Review

R Squared sold out of Clover Health Investments (CLOV) in Q2 2026, closing a stake of 37,442 shares — an estimated $65.9K sold.

R Squared first reported a position in CLOV in Q1 2026 and held it in 1 quarter. The position peaked at $65.9K in Q1 2026. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

R Squared reported no remaining Clover Health Investments position as of Q2 2026 after selling out during the quarter.
R Squared sold 37,442 Clover Health Investments shares in Q2 2026, an estimated $65.9K.
R Squared first reported a position in Clover Health Investments in Q1 2026 and held it in 1 quarter.
R Squared's Clover Health Investments position peaked at $65.9K in Q1 2026.
226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.